Compare GlobalFoundries Inc. Ordinary Shares (GFS) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GlobalFoundries Inc. Ordinary Shares vs Inovio Pharmaceuticals Inc — how do they compare? GlobalFoundries Inc. Ordinary Shares trades at $48.24 (market cap $27.51B), while Inovio Pharmaceuticals Inc trades at $1.15 (market cap $112.19M). The key difference: GlobalFoundries Inc. Ordinary Shares is far larger — about 245.2× Inovio Pharmaceuticals Inc's market cap, and GlobalFoundries Inc. Ordinary Shares pays a 0.97% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold GlobalFoundries Inc. Ordinary Shares for 0 Days and Inovio Pharmaceuticals Inc for 43 Days on average.
| GFS | INO | |
|---|---|---|
Market Cap | $27.51B | $112.19M |
Volume | 10,416,572 | 3,201,278 |
Sector | Technology | Health |
52-Week High | $89.96 | $2.65 |
52-Week Low | $32.24 | $0.66 |
Typical Hold Time | 0 Days | 43 Days |
Enterprise Value | $26.80B | $83.51M |
Dividend Yield | 0.97% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
INO Pharmaceuticals trades at $1.09, down 5.63% today, with a bearish technical outlook despite positive analyst sentiment. The company faces significant fundamental challenges with minimal revenue of $65,340 in 2025 and substantial losses of $84.95 million. Key catalyst is the October 30, 2026 FDA decision on INO-3107 for recurrent respiratory papillomatosis, which could transform the company's prospects if approved.
Investment outlook hinges on FDA approval of INO-3107, with analysts maintaining a $2.75 consensus target representing 152% upside. However, persistent cash burn and negative profitability metrics pose substantial risks. The stock offers high-risk, high-reward potential for investors comfortable with binary regulatory outcomes in biotech.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GlobalFoundries Inc. Ordinary Shares
GlobalFoundries is a semiconductor foundry that manufactures chips for other companies. Its technologies serve automotive, communications, industrial, and consumer markets.
Read more on GFS →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
